Martingale Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,800
Closed -$254K 845
2022
Q3
$254K Buy
+7,800
New +$322K 0.01% 740

Other funds holding EXAS

Martingale Asset Management's EXAS Position: Q4 2022 in Review

Martingale Asset Management sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 7,800 shares — an estimated $254K sold.

Martingale Asset Management first reported a position in EXAS in Q3 2022 and held it in 1 quarter. The position peaked at $254K in Q3 2022. 551 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Martingale Asset Management reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Martingale Asset Management sold 7,800 Exact Sciences shares in Q4 2022, an estimated $254K.
  • Martingale Asset Management first reported a position in Exact Sciences in Q3 2022 and held it in 1 quarter.
  • Martingale Asset Management's Exact Sciences position peaked at $254K in Q3 2022.
  • 551 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Martingale Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.